A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity. Karki K, Wright GA, Mohankumar K, Jin UH, et al. Cancer Res 2020;80:1011-1023.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karki K, Wright GA, Mohankumar K, Jin UH, et al. A Bis-Indole-Derived NR4A1 Antagonist Induces PD-L1 Degradation and Enhances Antitumor Immunity. Cancer Res 2020;80:1011-1023.
PMID: 31911554